$16.08
2.84% yesterday
NYSE, Jul 09, 10:19 pm CET
ISIN
US6877931096
Symbol
OSCR

Oscar Health Target price 2025 - Analyst rating & recommendation

Oscar Health Classifications & Recommendation:

Buy
56%
Hold
31%
Sell
13%

Oscar Health Price Target

Target Price $16.32
Price $16.08
Potential
Number of Estimates 11
11 Analysts have issued a price target Oscar Health 2026 . The average Oscar Health target price is $16.32. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 9 Analysts recommend Oscar Health to buy, 5 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Oscar Health stock has an average upside potential 2026 of . Most analysts recommend the Oscar Health stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 9.18 11.55
56.54% 25.81%
EBITDA Margin 0.97% 3.27%
127.87% 235.65%
Net Margin 0.28% 1.55%
106.00% 459.39%

12 Analysts have issued a sales forecast Oscar Health 2025 . The average Oscar Health sales estimate is

$11.5b
Unlock
. This is
15.10% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$12.5b 24.38%
Unlock
, the lowest is
$10.8b 7.96%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $9.2b 56.54%
2025
$11.5b 25.81%
Unlock
2026
$11.5b 0.47%
Unlock
2027
$13.3b 16.04%
Unlock

12 Analysts have issued an Oscar Health EBITDA forecast 2025. The average Oscar Health EBITDA estimate is

$377m
Unlock
. This is
88.62% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$421m 110.38%
Unlock
, the lowest is
$303m 51.74%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $89.4m 143.63%
2025
$377m 321.70%
Unlock
2026
$416m 10.24%
Unlock
2027
$730m 75.56%
Unlock

EBITDA Margin

2024 0.97% 127.87%
2025
3.27% 235.65%
Unlock
2026
3.62% 10.70%
Unlock
2027
5.47% 51.10%
Unlock

11 Oscar Health Analysts have issued a net profit forecast 2025. The average Oscar Health net profit estimate is

$178m
Unlock
. This is
44.65% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$234m 89.91%
Unlock
, the lowest is
$147m 18.83%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $25.4m 109.39%
2025
$178m 601.57%
Unlock
2026
$186m 4.35%
Unlock
2027
$424m 127.78%
Unlock

Net Margin

2024 0.28% 106.00%
2025
1.55% 459.39%
Unlock
2026
1.62% 4.52%
Unlock
2027
3.18% 96.30%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.10 0.70
108.20% 600.00%
P/E 23.52
EV/Sales 0.34

11 Analysts have issued a Oscar Health forecast for earnings per share. The average Oscar Health EPS is

$0.70
Unlock
. This is
75.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.92 130.00%
Unlock
, the lowest is
$0.58 45.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.10 108.20%
2025
$0.70 600.00%
Unlock
2026
$0.73 4.29%
Unlock
2027
$1.67 128.77%
Unlock

P/E ratio

Current 40.20 88.02%
2025
23.52 43.15%
Unlock
2026
22.54 4.17%
Unlock
2027
9.89 56.12%
Unlock

Based on analysts' sales estimates for 2025, the Oscar Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.44 27.87%
2025
0.34 12.79%
Unlock
2026
0.34 0.47%
Unlock
2027
0.29 13.81%
Unlock

P/S ratio

Current 0.41 28.12%
2025
0.31 13.14%
Unlock
2026
0.32 0.48%
Unlock
2027
0.27 13.81%
Unlock

Current Oscar Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
Locked
Locked Jul 02 2025
Piper Sandler
Locked
Locked
Locked Jun 09 2025
Wells Fargo
Locked
Locked
Locked Mar 13 2025
Jefferies
Locked
Locked
Locked Dec 10 2024
B of A Securities
Locked
Locked
Locked Nov 06 2024
UBS
Locked
Locked
Locked Oct 07 2024
Piper Sandler
Locked
Locked
Locked Sep 10 2024
Analyst Rating Date
Locked
Barclays:
Locked
Locked
Jul 02 2025
Locked
Piper Sandler:
Locked
Locked
Jun 09 2025
Locked
Wells Fargo:
Locked
Locked
Mar 13 2025
Locked
Jefferies:
Locked
Locked
Dec 10 2024
Locked
B of A Securities:
Locked
Locked
Nov 06 2024
Locked
UBS:
Locked
Locked
Oct 07 2024
Locked
Piper Sandler:
Locked
Locked
Sep 10 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today